Using Zydis® ODT To Solve Delivery Challenges For Tolerogenic Vaccines

Originally published in Pharmaceutical Technology.
Respiratory allergic disease is one of the most widespread chronic health conditions in the world, yet despite this prevalence, delivery formats for these therapeutics are surprisingly limited. The Zydis® orally dissolving tablet (ODT) platform from Catalent is a freeze-dried (lyophilized) oral solid dosage form that disperses instantly in the mouth and provides unique delivery routes for allergy immunotherapies.
Learn about the advantages offered by the freeze dried Zydis ODT relating to large molecule storage, aggregation, and in some cases, protease activity.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.